Targeting pattern recognition receptors in cancer immunotherapy
Nadège Goutagny1, Yann Estornes, Uzma Hasan
1Université de Lyon, Université Lyon I, UMR INSERM 1052 CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France. nadege.goutagny@lyon.unicancer.fr
Targeted Oncology
|March 9, 2012
Summary
Pattern recognition receptors (PRRs) activate the immune system and are key in cancer therapy. Understanding PRR activation in tumor cells versus the microenvironment is crucial for developing effective cancer treatments.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Pattern recognition receptors (PRRs) mediate innate immunity by recognizing microbial products.
- Activation of the immune system via PRRs is crucial for anti-tumor responses.
- Toll-like receptors (TLRs), a family of PRRs, show anti-cancer activity and are in clinical trials.
Purpose of the Study:
- To review the dual role of PRR activation in tumor cells and the tumor microenvironment.
- To discuss the implications of PRR ligand therapy in cancer treatment.
- To highlight prospects for clinical development of PRR agonists.
Main Methods:
- Literature review of recent advances in PRR research.
- Analysis of studies on TLR activation in cancer.
- Discussion of intrinsic vs. extrinsic PRR activation effects.
Main Results:
- PRR activation can have context-dependent pro- or anti-tumor effects.
- TLR ligands demonstrate anti-tumoral activities and are investigated as cancer therapeutics.
- Understanding the balance of PRR activation is key for optimizing cancer therapy.
Conclusions:
- PRR agonists offer promising therapeutic avenues for cancer treatment.
- Further research into PRR expression and activation mechanisms is warranted.
- Careful consideration of PRR activation context is essential for clinical success.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...